1. Home
  2. LXRX vs LXFR Comparison

LXRX vs LXFR Comparison

Compare LXRX & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • LXFR
  • Stock Information
  • Founded
  • LXRX 1995
  • LXFR 1898
  • Country
  • LXRX United States
  • LXFR United States
  • Employees
  • LXRX N/A
  • LXFR N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • LXFR Major Chemicals
  • Sector
  • LXRX Health Care
  • LXFR Industrials
  • Exchange
  • LXRX Nasdaq
  • LXFR Nasdaq
  • Market Cap
  • LXRX 352.5M
  • LXFR 370.4M
  • IPO Year
  • LXRX 2000
  • LXFR 2012
  • Fundamental
  • Price
  • LXRX $0.75
  • LXFR $13.84
  • Analyst Decision
  • LXRX Buy
  • LXFR
  • Analyst Count
  • LXRX 2
  • LXFR 0
  • Target Price
  • LXRX $6.00
  • LXFR N/A
  • AVG Volume (30 Days)
  • LXRX 4.9M
  • LXFR 99.2K
  • Earning Date
  • LXRX 11-12-2024
  • LXFR 10-29-2024
  • Dividend Yield
  • LXRX N/A
  • LXFR 3.78%
  • EPS Growth
  • LXRX N/A
  • LXFR 57.96
  • EPS
  • LXRX N/A
  • LXFR 0.34
  • Revenue
  • LXRX $5,229,000.00
  • LXFR $384,400,000.00
  • Revenue This Year
  • LXRX $886.38
  • LXFR N/A
  • Revenue Next Year
  • LXRX $181.58
  • LXFR $3.44
  • P/E Ratio
  • LXRX N/A
  • LXFR $40.54
  • Revenue Growth
  • LXRX 886.60
  • LXFR N/A
  • 52 Week Low
  • LXRX $0.62
  • LXFR $7.55
  • 52 Week High
  • LXRX $3.73
  • LXFR $15.64
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 38.05
  • LXFR 46.73
  • Support Level
  • LXRX $0.72
  • LXFR $13.54
  • Resistance Level
  • LXRX $0.85
  • LXFR $14.02
  • Average True Range (ATR)
  • LXRX 0.09
  • LXFR 0.44
  • MACD
  • LXRX 0.03
  • LXFR -0.10
  • Stochastic Oscillator
  • LXRX 33.10
  • LXFR 17.20

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: